AR022482A1 - Metodos y composiciones para usar en aplicaciones de perfusion - Google Patents

Metodos y composiciones para usar en aplicaciones de perfusion

Info

Publication number
AR022482A1
AR022482A1 ARP000100449A ARP000100449A AR022482A1 AR 022482 A1 AR022482 A1 AR 022482A1 AR P000100449 A ARP000100449 A AR P000100449A AR P000100449 A ARP000100449 A AR P000100449A AR 022482 A1 AR022482 A1 AR 022482A1
Authority
AR
Argentina
Prior art keywords
methods
compositions
fluid
applications
composition
Prior art date
Application number
ARP000100449A
Other languages
English (en)
Spanish (es)
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotime Inc filed Critical Biotime Inc
Publication of AR022482A1 publication Critical patent/AR022482A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
ARP000100449A 1999-02-03 2000-02-02 Metodos y composiciones para usar en aplicaciones de perfusion AR022482A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/243,921 US6589223B1 (en) 1999-02-03 1999-02-03 Method and compositions for use in perfusion applications

Publications (1)

Publication Number Publication Date
AR022482A1 true AR022482A1 (es) 2002-09-04

Family

ID=22920663

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100449A AR022482A1 (es) 1999-02-03 2000-02-02 Metodos y composiciones para usar en aplicaciones de perfusion

Country Status (14)

Country Link
US (3) US6589223B1 (enExample)
EP (1) EP1150728A4 (enExample)
JP (2) JP2002536078A (enExample)
CN (1) CN1200742C (enExample)
AR (1) AR022482A1 (enExample)
AU (1) AU765144B2 (enExample)
BR (1) BR0008006A (enExample)
CA (1) CA2362051C (enExample)
EA (1) EA003171B1 (enExample)
IL (1) IL144710A0 (enExample)
MX (1) MXPA01007875A (enExample)
TW (1) TW542728B (enExample)
WO (1) WO2000045873A1 (enExample)
ZA (1) ZA200107243B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6718735B2 (en) * 2002-03-19 2004-04-13 Baxter International Inc. Albumin in a flexible polymeric container
US7354342B2 (en) * 2003-07-30 2008-04-08 Igt Gaming device having a multiple coordinate award distributor including award percentages
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) * 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US8585380B2 (en) 2004-10-07 2013-11-19 Transmedics, Inc. Systems and methods for ex-vivo organ care
US20100121273A1 (en) * 2005-06-22 2010-05-13 Kochanek Patrick M Emergency preservation and resuscitation methods
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US7712094B2 (en) * 2005-12-22 2010-05-04 Alan Joshua Shapiro Method and apparatus for replicating a panoplex onto a storage medium from a master
DK1942726T3 (en) * 2006-04-19 2017-04-10 Transmedics Inc METHODS FOR EX VIVO ORGANIC CARE
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
KR101183965B1 (ko) * 2007-10-05 2012-09-18 후소 야쿠힝 고교 가부시끼가이샤 안정한 탄산수소 이온 함유 약액
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US9247728B2 (en) 2008-01-31 2016-02-02 Transmedics, Inc. Systems and methods for ex vivo lung care
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
DK4032401T3 (da) 2011-04-14 2025-12-15 Transmedics Inc Fremgangsmåde til fremstilling af en organplejeopløsning til maskinperfusion ex-vivo af donorlunger
US8579880B2 (en) * 2012-03-01 2013-11-12 Outcome Solutions, Llc Devices and methods for making and administering an intravenous liquid with supersaturated dissolved gas
IL303658B2 (en) 2014-06-02 2024-07-01 Transmedics Inc Ex vivo organ care system
DK3229588T3 (da) 2014-12-12 2025-06-23 Transmedics Inc Anordning og fremgangsmåde til organperfusion
DK3347084T3 (da) 2015-09-09 2021-02-15 Transmedics Inc Aortakanyle til ex vivo-organplejesystem
DK3462861T5 (da) 2016-05-30 2024-01-08 Transmedics Inc Fremgangsmåde til ex vivo-lungeventilati on med et varierende udvendigt tryk

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3677024A (en) 1970-01-20 1972-07-18 Paul E Segall Preservation and storage of biologic materials
US3937821A (en) 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US4001401A (en) 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4061736A (en) 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
DE2801123C2 (de) 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
EP0185759B2 (en) 1984-06-22 2004-06-02 Btg International Limited Electrolyte solutions and (in vivo) use thereof
US5084377A (en) 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4908350A (en) 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US5210083A (en) 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
WO1989005659A1 (en) 1987-12-24 1989-06-29 Borody Thomas J Orthostatic lavage solutions
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US5082831A (en) 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
CA2066374C (en) 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
EP0663821A4 (en) 1991-08-08 1997-09-17 Leigh D Segel BLOOD SUBSTITUTE WITH FLUOROCARBON.
US5334142A (en) * 1991-09-09 1994-08-02 New York University Selective aortic perfusion system
US5374428A (en) * 1993-03-23 1994-12-20 Kansas State University Research Foundation Supplementation of protein diets with di- and tripeptides
US5407428A (en) 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes
CN1102851C (zh) * 1993-06-04 2003-03-12 生物时间公司 类血浆溶液
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US5730720A (en) 1995-08-18 1998-03-24 Ip Scientific, Inc. Perfusion hyperthermia treatment system and method
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications

Also Published As

Publication number Publication date
CN1200742C (zh) 2005-05-11
CA2362051A1 (en) 2000-08-10
AU3349700A (en) 2000-08-25
EP1150728A4 (en) 2004-09-29
EA200100855A1 (ru) 2002-02-28
JP2002536078A (ja) 2002-10-29
BR0008006A (pt) 2001-12-04
MXPA01007875A (es) 2002-08-20
JP5180912B2 (ja) 2013-04-10
TW542728B (en) 2003-07-21
US7503913B2 (en) 2009-03-17
JP2009242404A (ja) 2009-10-22
AU765144B2 (en) 2003-09-11
IL144710A0 (en) 2002-06-30
CN1346286A (zh) 2002-04-24
EA003171B1 (ru) 2003-02-27
US20040018966A1 (en) 2004-01-29
US6589223B1 (en) 2003-07-08
ZA200107243B (en) 2002-09-02
US20060088606A1 (en) 2006-04-27
WO2000045873A1 (en) 2000-08-10
EP1150728A1 (en) 2001-11-07
US6991624B2 (en) 2006-01-31
CA2362051C (en) 2010-06-29

Similar Documents

Publication Publication Date Title
AR022482A1 (es) Metodos y composiciones para usar en aplicaciones de perfusion
de Chalain Exploring the use of the medicinal leech: a clinical risk-benefit analysis
Sheldon et al. Cutaneous mucormycosis: two documented cases of suspected nosocomial cause
Chen et al. The comparison of 2 new promising weapons for the treatment of hydatid cyst disease: PAIR and laparoscopic therapy
Chen et al. Laparoscopic surgical techniques in patients with hepatic hydatid cyst
TW200501932A (en) Sterile combined preparation and manufacture method thereof
AR045070A1 (es) Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico
MX9206335A (es) Composicion de difusion de tejido ex vivo para la difusion de tejidos y organos.
Koval et al. Posttraumatic tibial osteomyelitis: a comparison of three treatment approaches
Tremaine Infection of equine joints and tendon sheaths
Solanki et al. Pedicled gracilis myocutaneous flap for treatment of recalcitrant hidradenitis suppurativa of the groin and perineum
Halseth et al. Pulmonary actinomycosis treated by lung resection
Iannini et al. Severe sepsis from Enterobacter
ALLEN et al. Sulfathiazole ointment in the treatment of burns
Park et al. Atraumatic compartment syndrome: a manifestation of toxic shock and infectious pyomyositis in a child: a case report
Gouin et al. Office management of minor wounds.
HURLEY et al. Chronic osteomyelitis: Treatment by regional perfusion with antibiotics
Makins The development of British surgery in the hospitals on the lines of communication in France
Streets Lessons from the battlefield in the management of major trauma
Gwathmey The Three-Table Military Operating Room A Plan Applicable to Civil Hospitals
BR0109525A (pt) Composição, uso de uma composição, tabletes ou cápsulas, e, método de preparação de uma solução ou suspensão
Ryssel et al. Necrotizing fasciitis after a honey bee sting
Rijal et al. Use of ring fixator in the management of degloving injuries of lower limb
Sallam et al. DELAYED DEBRIDEMENT FOR NECROTIZING SOFT TISSUE INFECTIONS: EXPERIENCE WITH IMMUNOCOMPROMISED PEDIATRIC CANCER PATIENTS.
Cope Thrombo-angitis obliterans of the spermatic cord

Legal Events

Date Code Title Description
FC Refusal